OSSDSIGN AB
OssDsign was founded in May 2011 by Professor Håkan Engqvist, Dr Thomas Engstrand, Bo Qwarnstrom, Jonas Åberg, Uppsala University AB and other leading clinical, preclinical and materials researchers and engineers. The key people in the company are presented below. OssDsign has in addition developed a network of international experts in Clinical Affairs, Regulatory and Business Development.
OSSDSIGN AB
Industry:
Biotechnology Clinical Trials Health Care Medical
Founded:
2011-06-01
Address:
Uppsala, Uppsala Lan, Sweden
Country:
Sweden
Website Url:
http://www.ossdsign.com
Total Employee:
11+
Status:
Active
Contact:
46 18 55 39 93
Email Addresses:
[email protected]
Total Funding:
12.48 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Google Maps LinkedIn Insights LinkedIn Ads Fonts.com
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-11-03 | Sirakoss | Sirakoss acquired by OssDsign AB | 11 M USD |
Investors List
Fouriertransform
Fouriertransform investment in Venture Round - OssDsign AB
Almi Invest
Almi Invest investment in Venture Round - OssDsign AB
SEB Venture Capital
SEB Venture Capital investment in Venture Round - OssDsign AB
Karolinska
Karolinska investment in Venture Round - OssDsign AB
Karolinska
Karolinska investment in Venture Round - OssDsign AB
Key Employee Changes
Official Site Inspections
http://www.ossdsign.com
- Host name: dedserv4081.levonline.com
- IP address: 217.70.37.81
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
More informations about "OssDsign AB"
OssDsign
OssDsign Catalyst is the first synthetic bone graft to be cleared to market for interbody use based on bone graft data alone, allowing on-label use in any interbody cage cleared for use with synthetic bone grafts. More about …See details»
OssDsign AB - Crunchbase Company Profile & Funding
OssDsign was founded in May 2011 by Professor Håkan Engqvist, Dr Thomas Engstrand, Bo Qwarnstrom, Jonas Åberg, Uppsala University AB and other leading clinical, preclinical and …See details»
History - OssDsign AB
OssDsign was founded in 2011 based on a collaboration between Uppsala University and Karolinska University and in 2019, the company was listed on Nasdaq First North Growth Market in Stockholm, Sweden. For the first …See details»
OssDsign - LinkedIn
OssDsign is a developer and global provider of next generation orthobiologics products. Based on cutting edge material science, the company develops and markets products that support the body's ...See details»
OssDsign Company Profile 2024: Stock Performance
OssDsign AB is a developer and global provider of next-generation orthobiologics products. The company's product OssDsign Catalyst is a bone graft that stimulates the formation of healthy bone tissue in spinal fusion surgeries. …See details»
OssDsign AB Company Description - Stock Analysis
Oct 29, 2024 It offers OssDsign Catalyst, a nanosynthetic bone graft used to help stimulate bone growth in spinal fusions. The company was founded in 2011 and is headquartered in Uppsala, …See details»
OssDsign AB, OSSD:STO profile - FT.com - Financial Times
Nov 21, 2024 OssDsign AB, formerly known as Oss-Q AB is a Sweden-based orthopedic medical device company. It aims at developing implantable products that respond to clinical …See details»
OssDsign - Products, Competitors, Financials, Employees, …
OssDsign's share is traded on Nasdaq First North Growth Market in Stockholm, Sweden. The Company’s Certified Adviser is Carnegie Investment Bank AB (publ). Morten Henneveld, CEO, …See details»
OssDsign Company Profile - Office Locations, Competitors ... - Craft
Oct 25, 2024 OssDsign has 4 employees across 3 locations and kr112.16 m in annual revenue in FY 2023. See insights on OssDsign including office locations, competitors, revenue, …See details»
OssDsign - Karolinska Development
OssDsign is a developer and global provider of next generation orthobiologics products. Based on cutting edge material science, the company develops and markets products that support the …See details»
Sustainability - OssDsign AB
The company has established a “whistleblower” procedure by which employees can confidentially raise concerns or complaints anonymously using [email protected]. Quality We …See details»
OssDsign announces strategic shift to become a pure play …
Uppsala, September 26, 2023, 17:31 CEST. OssDsign AB (publ) today announced a strategic shift to focus its operations on the orthobiologics business in the U.S, in order to increase …See details»
5,000 patients treated with OssDsign Catalyst® in the U.S.
May 30, 2024 Morten Henneveld, CEO, OssDsign AB Tel: +46 73 382 43 90, email: [email protected]. Certified Adviser. The Company’s Certified Adviser is …See details»
OssDsign AB (OSSD) Stock Price & News - Google Finance
Get the latest OssDsign AB (OSSD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.See details»
Board of Directors - OssDsign AB
Board member since 2024. Born: 1965 Education and experience: Christer Fåhraeus has thirty years of experience as CEO, board member, and chairman from fast-growing listed and …See details»
Notice to attend the extraordinary general meeting in OssDsign AB
5 hours ago The shareholders in OssDsign AB, reg. no. 556841-7546, are hereby given notice to attend the extraordinary general meeting at 10:00 am on Wednesday 18 December 2024 at …See details»
Kallelse till extra bolagsstämma i OssDsign AB - OssDsign AB
6 hours ago Morten Henneveld, VD, OssDsign AB Tel: +46 73 382 43 90 [email protected] . Certified Adviser: Bolagets Certified Adviser är Carnegie …See details»
OssDsign
OssDsign is using the SecureMailbox authorization service to secure and simplify your login. Powered by SecureAppboxSee details»
OssDsign Catalyst
Traditional synthetics focus only on the intramembranous bone formation pathway, whereas the human body uses two bone formation pathways to produce bone: the intramembranous …See details»
News - OssDsign AB
This website uses cookies to improve your user experience, to provide a basis for improvement and further development of the website and to be able to direct more relevant offers to you.See details»